The Binding Site. Inc.
San Diego, CA Part of Thermo Fisher Scientific Inc.
- UEI
- ETZEQNG96NN5
- CAGE
- 054P3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Thermo Fisher Scientific Inc. · Waltham, MA
GK3LCBGHLUK6
-
Parent
Thermo Fisher Scientific Inc. · Waltham, MA
GK3LCBGHLUK6
- SAM.gov registration date
- Physical address
- 9606 Kearny Villa Rd, San Diego, CA 92126, USA
- Website
- thermofisher.com
- Founded
- 1956
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $139,970 |
| FY2026 | $1,887,747 |
| FY2025 | $1,558,085 |
| FY2024 | $1,910,119 |
| FY2023 | $1,402,216 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,934,658 | |
| 2 | Department of Health and Human Services | $93,059 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fisher Healthcare | Pittsburgh, PA | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| One Lambda, Inc. | Los Angeles, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Roche Diagnostics Corporation | Indianapolis, IN | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Gold Standard Diagnostics, LLC | Davis, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Meridian Bioscience Inc. | Cincinnati, OH | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
The Binding Site. Inc., a wholly owned subsidiary of Thermo Fisher Scientific Inc., supplies specialized laboratory diagnostic equipment, reagents, and testing services to federal healthcare agencies as a prime contractor, operating exclusively in the full-and-open competitive space with no socioeconomic set-asides. Headquartered in San Diego, California, The Binding Site. Inc. is a for-profit medical diagnostics company that manufactures in-vitro diagnostic substances and analytical laboratory instruments (NAICS 325413 and 541380; PSC codes 6630 and 6640). The company competes in open market awards across 24 distinct federal customer agencies, with concentrated work at the Department of Veterans Affairs and Defense Health Agency.
The Binding Site. Inc.'s recent award footprint spans 424 prime contracts and IDVs with a combined potential value of $59.9 million, of which $19 million is obligated (32% realization). Activity has remained steady over the past five years, averaging 13 awards annually, with 17 awards in 2025 and three awards through November 2026. Two representative contracts illustrate the portfolio: a $643,696 single-award IDIQ with Veterans Integrated Service Network 12 (awarded September 2022, running through October 2027) for Optilite Analyzers and reagents, which has generated five delivery orders totaling over $665 thousand in obligated value; and a $1.47 million blanket purchase agreement with VISN 22 (awarded March 2023, through March 2028) for reagents and supplies supporting clinical pathology, with recent BPA calls ranging from $240 thousand to $1.04 million each. A third example, the $2.1 million single-award IDIQ with VISN 10 for Optilite reagents (awarded March 2022, through February 2027), has sustained multiple delivery orders under a cost-per-unit model, with obligated values reaching $820 thousand in 2025 alone.
Customer concentration centers heavily on the Veterans Affairs system and defense healthcare. The top five customers account for 62% of combined potential value, with the Defense Health Agency leading at $8.9 million across 10 awards, VISN 8 following at $8.5 million across 41 awards, VISN 1 at $7 million across 24 awards, VISN 10 at $6.9 million across 13 awards, and the Navy Bureau of Medicine and Surgery at $6 million across 8 awards. By award count, VISN 8 dominates with 41 awards, followed by VISN 16 (26), VISN 1 (24), and VISN 2 (24); these five VISNs and DHA collectively represent 33% of all awards. This concentration reflects The Binding Site's positioning as a specialized vendor for proprietary protein analyzers and free light-chain assay kits (Optilite, Kappa Lambda, HevyLite, Freelight systems) that address narrow clinical diagnostic requirements within established VA and DHA networks.
Parent vehicles sustain the order flow. The company places 38 task orders under a "Scientific Equipment and Services" vehicle ($2.3 million combined potential), seven calls under BPA HT001419A0010 ($768 thousand), seven under IDIQ VA52815D0110 ($265 thousand), six under BPA 36C24120A0043 ($1.6 million), and six under IDIQ 36C25222D0060 ($813 thousand). These single-award IDIQs and BPAs function as standing suppliers of reagents, analyzers, and maintenance services across multiple VA regions, with call orders placed monthly or quarterly to replenish consumables and exercise option years.
Recompete exposure in the next twenty-four months totals 14 awards worth $4.8 million in combined potential value, representing 8% of the portfolio. Award capability concentration in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) carries 128 awards, with 99 in Analytical Laboratory Instrument Manufacturing, signaling The Binding Site's role as both equipment manufacturer and reagent supplier. PSC code concentration mirrors this: 142 awards under In Vitro Diagnostic Substances (PSC 6630) and 141 under Laboratory Equipment and Supplies (PSC 6640), with smaller volumes in medical instruments and biologicals. The portfolio reflects a niche, mission-critical position supplying proprietary diagnostic platforms that anchor long-term relationships with VA clinical laboratories and military treatment facilities, with minimal subcontracting exposure and strong renewal momentum in established VISN and DHA networks.
SBA capabilities narrative
IMMUNOLOGY RELATED PRODUCTS; ANTISERA, CONJUGATES, DIAGNOSTIC MEDICAL, RESEARCH AND VETERINARY KITS; LABORATORY SUPPLIES, MEDICAL.
Quick answers
Is The Binding Site. Inc. registered in SAM.gov?
Yes. The Binding Site. Inc.'s SAM.gov registration is active through April 14, 2027.
Which contract vehicles does The Binding Site. Inc. hold?
The Binding Site. Inc. holds a place on 1 federal contract vehicle: FSS-66.
How much has The Binding Site. Inc. received in federal contracts?
Federal contracts obligated $1,558,085 to The Binding Site. Inc. in fiscal year 2025 and $6,898,136 in fiscal years 2023 through 2027.
How does The Binding Site. Inc. rank among federal contractors?
The Binding Site. Inc. ranked #25 in NAICS 325413, #35 in PSC 6550 and #44 in NAICS 325414 in FY2025.
What is The Binding Site. Inc.'s most recent federal award?
The Binding Site. Inc.'s most recent federal contract award is Optilite analyzer, reagents, P00001 - EO 14398 (36C25227N0117), from Veterans Integrated Service Network 12 (VHA), on November 1, 2026.
On GovTribe
See The Binding Site. Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors